{"parse":{"title":"Closed system drug transfer device","pageid":24712166,"revid":858236100,"text":{"*":"<div class=\"mw-parser-output\"><p>A <b>closed system drug transfer device</b> or \"CSTD\" is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system. Open versus closed systems are commonly applied in medical devices to maintain the sterility of a fluid pathway. CSTDs work by preventing the uncontrolled inflow and outflow of contaminants and drugs, preserving the quality of solution to be infused into a patient. Theoretically, CSTDs should enable complete protection to healthcare workers in managing hazardous drugs, but possibly due to improper handling or incomplete product design, contaminants can still be detected despite use of CSTDs.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Medical_use\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Medical use</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Efficacy\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Efficacy</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#History\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Definition\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Definition</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#NIOSH\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">NIOSH</span></a></li>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#ISOPP\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">ISOPP</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#NIOSH_Vapor_Containment_Protocol_Proposal_Comment_Period_Developments\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">NIOSH Vapor Containment Protocol Proposal Comment Period Developments</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Solutions\"><span class=\"tocnumber\">4.4</span> <span class=\"toctext\">Solutions</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Medical_use\">Medical use</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Closed_system_drug_transfer_device&amp;action=edit&amp;section=1\" title=\"Edit section: Medical use\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Hazardous drugs are often used for patients suffering from cancer.<sup id=\"cite_ref-Cochrane_2018_Gurusamy_2-0\" class=\"reference\"><a href=\"#cite_note-Cochrane_2018_Gurusamy-2\">&#91;2&#93;</a></sup> For example, <a href=\"/wiki/Chemotherapy\" title=\"Chemotherapy\">chemotherapy</a> agents are routinely used in the treatment of cancer. However, chemotherapy can be dangerous to a person even if they don't have cancer, as chemotherapy often indiscriminately affects both healthy and cancerous cells.<sup id=\"cite_ref-ACS_Chemo_3-0\" class=\"reference\"><a href=\"#cite_note-ACS_Chemo-3\">&#91;3&#93;</a></sup> For the healthcare worker tasked with preparing hazardous medications like chemotherapy, manipulation of these agents presents a substantial risk; for example, it may negatively affect their fertility, increase their risk of developing certain cancers themselves, or have unwelcome effects on fetuses.<sup id=\"cite_ref-Cochrane_2018_Gurusamy_2-1\" class=\"reference\"><a href=\"#cite_note-Cochrane_2018_Gurusamy-2\">&#91;2&#93;</a></sup> As an addition to standard safe handling practices, CSTDs are devices that are designed to additionally limit exposure of hazardous drugs to the personnel that manipulate them.<sup id=\"cite_ref-Cochrane_2018_Gurusamy_2-2\" class=\"reference\"><a href=\"#cite_note-Cochrane_2018_Gurusamy-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Efficacy\">Efficacy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Closed_system_drug_transfer_device&amp;action=edit&amp;section=2\" title=\"Edit section: Efficacy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Investment and interests in CSTDs continue to grow<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> over the past decade as concerns of Occupational Safety and Health (OSH), together with increased awareness of drug risks have pushed the market to explore better options for handling hazardous materials. A <a href=\"/wiki/Cochrane_review\" class=\"mw-redirect\" title=\"Cochrane review\">Cochrane review</a> found \"no evidence for or against adding CSTD to safe handling of hazardous medicines\" based on a review of 23 studies, but acknowledged that the studies did not use randomised controlled trials nor evaluate the value of treatment. CSTDs used in this study include PhaSeal, Tevadaptor and SpikeSwan.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> It remains that new solutions to increasing safety of handling hazardous drugs have to be developed. Conceptually, through operating in a closed system, CSTDs should significantly reduce risks to nurses. However, the robustness of product design and extent of proper usage by nurses affects the efficacy of the CSTD in achieving OSH.\n</p>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Closed_system_drug_transfer_device&amp;action=edit&amp;section=3\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The first <a href=\"/wiki/FDA\" class=\"mw-redirect\" title=\"FDA\">FDA</a>-approved CSTD was in 1998, called PhaSeal. Since that time, many other CSTD products have been developed in the United States.<sup id=\"cite_ref-Massoomi_CSTD_Review_6-0\" class=\"reference\"><a href=\"#cite_note-Massoomi_CSTD_Review-6\">&#91;6&#93;</a></sup> <a href=\"/wiki/MD_Anderson\" class=\"mw-redirect\" title=\"MD Anderson\">MD Anderson</a> hospital was the first hospital in the United States to widely implement CSTD technology.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Definition\">Definition</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Closed_system_drug_transfer_device&amp;action=edit&amp;section=4\" title=\"Edit section: Definition\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The definition of a closed system drug transfer device was first published in an alert warning released by the American <a href=\"/wiki/National_Institute_for_Occupational_Safety_and_Health\" title=\"National Institute for Occupational Safety and Health\">National Institute for Occupational Safety and Health</a> (NIOSH). This warning was issued in relation to studies that showed a correlation between working with or near <a href=\"/wiki/Hazardous_drugs\" title=\"Hazardous drugs\">hazardous drugs</a> in a health care environment and the increased risk of developing skin rashes, infertility, miscarriage and infant birth defects, as well as the possibility of developing leukemia and other forms of cancer. This NIOSH alert recommended that a closed system drug transfer device be used whenever hazardous drugs were to be handled.\n</p>\n<h3><span class=\"mw-headline\" id=\"NIOSH\">NIOSH</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Closed_system_drug_transfer_device&amp;action=edit&amp;section=5\" title=\"Edit section: NIOSH\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>NIOSH, in response to the need for a working model as to what a \"closed system\" and what a \"closed system drug transfer device\" was, provided the following definition:\n</p>\n<ul><li>A closed system is a device that does not exchange unfiltered air or contaminants with the adjacent environment.<sup id=\"cite_ref-NIOSH_8-0\" class=\"reference\"><a href=\"#cite_note-NIOSH-8\">&#91;8&#93;</a></sup> This closed system definition originally referred to a <a href=\"/wiki/Biological_safety_cabinet\" class=\"mw-redirect\" title=\"Biological safety cabinet\">biological safety cabinet</a><sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> and not to the drug containment devices. A drug containment device is one that is both airtight and leakproof.<sup id=\"cite_ref-name_10-0\" class=\"reference\"><a href=\"#cite_note-name-10\">&#91;10&#93;</a></sup></li>\n<li>A closed system drug transfer device is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of hazardous drug or vapor concentrations outside the system.<sup id=\"cite_ref-NIOSH_8-1\" class=\"reference\"><a href=\"#cite_note-NIOSH-8\">&#91;8&#93;</a></sup></li></ul>\n<p>The NIOSH definition is the only definition that includes drug vapors.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> NIOSH considers the containment of vapor extremely important, such that in September 2015, NIOSH issued a Testing Protocol to assess the effectiveness of closed systems.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup> NIOSH developed and tested 5 CSTDs to assess its \"closeness.\" 2 of the 5 CSTDs tested passed. This protocol is aimed as being a test standard for CSTDs to assess the \"closeness\" of each system.\n</p>\n<h3><span class=\"mw-headline\" id=\"ISOPP\">ISOPP</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Closed_system_drug_transfer_device&amp;action=edit&amp;section=6\" title=\"Edit section: ISOPP\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>ISOPP, the <a href=\"/w/index.php?title=International_Society_of_Oncology_Pharmacy_Practitioners&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"International Society of Oncology Pharmacy Practitioners (page does not exist)\">International Society of Oncology Pharmacy Practitioners</a>, splits the definition of a closed system into two different categories:\n</p>\n<ul><li>The first defines \"closed\" in terms of microbiological contamination. This definition deals purely with introducing micro-organisms into a sterile product, and there is no consideration of the sterile product coming out of the vial contaminating the environment.<sup id=\"cite_ref-name_10-1\" class=\"reference\"><a href=\"#cite_note-name-10\">&#91;10&#93;</a></sup></li>\n<li>The second category defines \"closed\" in relation to chemical contamination and refers to drug transfer devices that mechanically prohibit the transfer of environment contaminants into the system and the escape of hazardous drug or vapour concentrations outside the system. ISOPP, however, agree that the NIOSH definition is the most comprehensive and complete.<sup id=\"cite_ref-name_10-2\" class=\"reference\"><a href=\"#cite_note-name-10\">&#91;10&#93;</a></sup></li></ul>\n<h3><span class=\"mw-headline\" id=\"NIOSH_Vapor_Containment_Protocol_Proposal_Comment_Period_Developments\">NIOSH Vapor Containment Protocol Proposal Comment Period Developments</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Closed_system_drug_transfer_device&amp;action=edit&amp;section=7\" title=\"Edit section: NIOSH Vapor Containment Protocol Proposal Comment Period Developments\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In September 2015, the CDC issued a proposal for a testing protocol designed to test various CSTDs on the market today to help healthcare decision makers decipher between various systems available on the market today.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup> This protocol had an initial close date of November 2015 but was extended until March 2016. Findings from \"Fred Massoomi's Response to Docket No. CDC-2015-0075, NIOSH-288\" include:\n</p>\n<ul><li>Testing performed under \"Report on NIOSH's Vapor Containment Performance Protocol for CSTDs\" showed that Equashield and PhaSeal systems had contamination below the 1ppm recommendation.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup></li>\n<li>Testing performed under \"5-FU leakage study\" showed that Equashield CSTD passed the leakage testing.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup></li>\n<li>Testing performed under \"Testing of Tevadaptor Efficiency in Preventing Cyclophosphamide\" showed that the Tevadaptor system FAILED the contain drug vapor within the system.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup></li></ul>\n<h3><span class=\"mw-headline\" id=\"Solutions\">Solutions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Closed_system_drug_transfer_device&amp;action=edit&amp;section=8\" title=\"Edit section: Solutions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Commercially available CSTD products include the following:<sup id=\"cite_ref-Page_Review_17-0\" class=\"reference\"><a href=\"#cite_note-Page_Review-17\">&#91;17&#93;</a></sup>\n</p>\n<ul><li>PhaSeal (BD, USA)</li>\n<li>Tevadaptor (Teva, Israel)</li>\n<li>Halo (Corvida, USA)</li>\n<li>ChemoClave (ICUmed, USA)</li>\n<li>Equashield II (Equashield, USA)</li>\n<li>NeoShield (JMS, Japan)</li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Closed_system_drug_transfer_device&amp;action=edit&amp;section=9\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Miyake, Tomohiro; Iwamoto, Takuya; Tanimura, Manabu; Okuda, Masahiro (2013-06-21). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3698436\">\"Impact of closed-system drug transfer device on exposure of environment and healthcare provider to cyclophosphamide in Japanese hospital\"</a>. <i>SpringerPlus</i>. <b>2</b>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/2193-1801-2-273\">10.1186/2193-1801-2-273</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/2193-1801\">2193-1801</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3698436\">3698436</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23853750\">23853750</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=SpringerPlus&amp;rft.atitle=Impact+of+closed-system+drug+transfer+device+on+exposure+of+environment+and+healthcare+provider+to+cyclophosphamide+in+Japanese+hospital&amp;rft.volume=2&amp;rft.date=2013-06-21&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3698436&amp;rft.issn=2193-1801&amp;rft_id=info%3Apmid%2F23853750&amp;rft_id=info%3Adoi%2F10.1186%2F2193-1801-2-273&amp;rft.aulast=Miyake&amp;rft.aufirst=Tomohiro&amp;rft.au=Iwamoto%2C+Takuya&amp;rft.au=Tanimura%2C+Manabu&amp;rft.au=Okuda%2C+Masahiro&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3698436&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AClosed+system+drug+transfer+device\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Cochrane_2018_Gurusamy-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Cochrane_2018_Gurusamy_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Cochrane_2018_Gurusamy_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Cochrane_2018_Gurusamy_2-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gurusamy, Kurinchi Selvan; Best, Lawrence MJ; Tanguay, Cynthia; Lennan, Elaine; Korva, Mika; Bussi\u00e8res, Jean-Fran\u00e7ois (27 March 2018). \"Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff\". <i>Cochrane Database of Systematic Reviews</i>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.CD012860.pub2\">10.1002/14651858.CD012860.pub2</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Closed-system+drug-transfer+devices+plus+safe+handling+of+hazardous+drugs+versus+safe+handling+alone+for+reducing+exposure+to+infusional+hazardous+drugs+in+healthcare+staff&amp;rft.date=2018-03-27&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD012860.pub2&amp;rft.aulast=Gurusamy&amp;rft.aufirst=Kurinchi+Selvan&amp;rft.au=Best%2C+Lawrence+MJ&amp;rft.au=Tanguay%2C+Cynthia&amp;rft.au=Lennan%2C+Elaine&amp;rft.au=Korva%2C+Mika&amp;rft.au=Bussi%C3%A8res%2C+Jean-Fran%C3%A7ois&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AClosed+system+drug+transfer+device\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ACS_Chemo-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ACS_Chemo_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy/how-chemotherapy-drugs-work.html\">\"How Chemotherapy Drugs Work\"</a>. <i>www.cancer.org</i>. American Cancer Society<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 May</span> 2018</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.cancer.org&amp;rft.atitle=How+Chemotherapy+Drugs+Work&amp;rft_id=https%3A%2F%2Fwww.cancer.org%2Ftreatment%2Ftreatments-and-side-effects%2Ftreatment-types%2Fchemotherapy%2Fhow-chemotherapy-drugs-work.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AClosed+system+drug+transfer+device\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">ltd, Research and Markets. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.researchandmarkets.com/research/z6wrsj/closed_system?w=5\">\"Closed System Drug Transfer Devices - Research and Markets\"</a>. <i>www.researchandmarkets.com</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2018-07-22</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.researchandmarkets.com&amp;rft.atitle=Closed+System+Drug+Transfer+Devices+-+Research+and+Markets&amp;rft.aulast=ltd&amp;rft.aufirst=Research+and+Markets&amp;rft_id=https%3A%2F%2Fwww.researchandmarkets.com%2Fresearch%2Fz6wrsj%2Fclosed_system%3Fw%3D5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AClosed+system+drug+transfer+device\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite id=\"CITEREFGurusamyBestTanguayLennan2018\" class=\"citation\">Gurusamy, Kurinchi Selvan; Best, Lawrence MJ; Tanguay, Cynthia; Lennan, Elaine; Korva, Mika; Bussi\u00e8res, Jean-Fran\u00e7ois (2018-03-27), <a rel=\"nofollow\" class=\"external text\" href=\"http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD012860.pub2/full\">\"Closed\u2010system drug\u2010transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff\"</a>, <i>The Cochrane Library</i>, John Wiley &amp; Sons, Ltd, <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/14651858.cd012860.pub2/full\">10.1002/14651858.cd012860.pub2/full</a><span class=\"reference-accessdate\">, retrieved <span class=\"nowrap\">2018-07-22</span></span></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Library&amp;rft.atitle=Closed%E2%80%90system+drug%E2%80%90transfer+devices+plus+safe+handling+of+hazardous+drugs+versus+safe+handling+alone+for+reducing+exposure+to+infusional+hazardous+drugs+in+healthcare+staff&amp;rft.date=2018-03-27&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.cd012860.pub2%2Ffull&amp;rft.aulast=Gurusamy&amp;rft.aufirst=Kurinchi+Selvan&amp;rft.au=Best%2C+Lawrence+MJ&amp;rft.au=Tanguay%2C+Cynthia&amp;rft.au=Lennan%2C+Elaine&amp;rft.au=Korva%2C+Mika&amp;rft.au=Bussi%C3%A8res%2C+Jean-Fran%C3%A7ois&amp;rft_id=http%3A%2F%2Fcochranelibrary-wiley.com%2Fdoi%2F10.1002%2F14651858.CD012860.pub2%2Ffull&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AClosed+system+drug+transfer+device\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Massoomi_CSTD_Review-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Massoomi_CSTD_Review_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Massoomi, Fred. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.pppmag.com/article/1638/\">\"The Evolution of the CSTD&#160;: February 2015&#160;: Oncology Safety - Pharmacy Purchasing &amp; Products Magazine\"</a>. <i>www.pppmag.com</i>. Ridgewood Medical Media LLC<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 May</span> 2018</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.pppmag.com&amp;rft.atitle=The+Evolution+of+the+CSTD+%3A+February+2015+%3A+Oncology+Safety+-+Pharmacy+Purchasing+%26+Products+Magazine&amp;rft.aulast=Massoomi&amp;rft.aufirst=Fred&amp;rft_id=https%3A%2F%2Fwww.pppmag.com%2Farticle%2F1638%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AClosed+system+drug+transfer+device\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Parks, Liz (March 2014). \"Are CSTDs at a Tipping Point in Nation's Hospitals?\". <i>Pharmacy Practice News</i>. p.&#160;16.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacy+Practice+News&amp;rft.atitle=Are+CSTDs+at+a+Tipping+Point+in+Nation%27s+Hospitals%3F&amp;rft.pages=16&amp;rft.date=2014-03&amp;rft.aulast=Parks&amp;rft.aufirst=Liz&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AClosed+system+drug+transfer+device\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-NIOSH-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NIOSH_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NIOSH_8-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a href=\"/wiki/National_Institute_for_Occupational_Safety_and_Health\" title=\"National Institute for Occupational Safety and Health\">National Institute for Occupational Safety and Health</a> (September 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.cdc.gov/niosh/docs/2004-165/2004-165d.html\">\"Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings\"</a>. <a href=\"/wiki/Centers_for_Disease_Control_and_Prevention\" title=\"Centers for Disease Control and Prevention\">Centers for Disease Control and Prevention</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">October 26,</span> 2009</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Preventing+Occupational+Exposure+to+Antineoplastic+and+Other+Hazardous+Drugs+in+Health+Care+Settings&amp;rft.pub=Centers+for+Disease+Control+and+Prevention&amp;rft.date=2004-09&amp;rft.au=National+Institute+for+Occupational+Safety+and+Health&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fniosh%2Fdocs%2F2004-165%2F2004-165d.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AClosed+system+drug+transfer+device\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://www.cdc.gov/od/ohs/biosfty/bsc/bsc.htm\">https://www.cdc.gov/od/ohs/biosfty/bsc/bsc.htm</a></span>\n</li>\n<li id=\"cite_note-name-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-name_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-name_10-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-name_10-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\">ISOPP Journal of Oncology Pharmacy Practice Volume 13, 2007, pg 28-29.</span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\">DHHS (NIOSH) Publication Number 2004\u2013165, September 2004.</span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-0003\">\"Regulations.gov\"</a>. <i>www.regulations.gov</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-11-03</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.regulations.gov&amp;rft.atitle=Regulations.gov&amp;rft_id=http%3A%2F%2Fwww.regulations.gov%2F%23%21documentDetail%3BD%3DCDC-2015-0075-0003&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AClosed+system+drug+transfer+device\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-0007\">https://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-0007</a></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\">CDC Comment CDC-2015-0075-0027 Attachment 2: <a rel=\"nofollow\" class=\"external free\" href=\"https://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-0027\">https://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-0027</a></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\">CDC Comment CDC-2015-0075-0027 Attachment 3: <a rel=\"nofollow\" class=\"external free\" href=\"https://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-0027\">https://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-0027</a></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\">CDC Comment CDC-2015-0075-0027 Attachment 1: <a rel=\"nofollow\" class=\"external free\" href=\"https://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-002\">https://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-002</a></span>\n</li>\n<li id=\"cite_note-Page_Review-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Page_Review_17-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Page, Michael. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.pharmacytimes.com/publications/health-system-edition/2016/may2016/closed-system-transfer-devices-design-characteristics-and-evolving-performance-standards\">\"Closed-System Transfer Devices: Design Characteristics and Evolving Performance Standards\"</a>. <i>www.pharmacytimes.com</i>. Pharmacy &amp; Healthcare Communications, LLC<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 May</span> 2018</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.pharmacytimes.com&amp;rft.atitle=Closed-System+Transfer+Devices%3A+Design+Characteristics+and+Evolving+Performance+Standards&amp;rft.aulast=Page&amp;rft.aufirst=Michael&amp;rft_id=http%3A%2F%2Fwww.pharmacytimes.com%2Fpublications%2Fhealth-system-edition%2F2016%2Fmay2016%2Fclosed-system-transfer-devices-design-characteristics-and-evolving-performance-standards&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AClosed+system+drug+transfer+device\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw1285\nCached time: 20180905213307\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.128 seconds\nReal time usage: 0.144 seconds\nPreprocessor visited node count: 607/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 21943/2097152 bytes\nTemplate argument size: 98/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 17587/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.054/10.000 seconds\nLua memory usage: 2.72 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  109.619      1 Template:Reflist\n100.00%  109.619      1 -total\n 42.09%   46.137      2 Template:Cite_journal\n 21.41%   23.470      6 Template:Cite_web\n  8.77%    9.612      1 Template:Citation\n  4.37%    4.794      1 Template:Cite_news\n  2.05%    2.242      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:24712166-0!canonical and timestamp 20180905213307 and revision id 858236100\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","*":"Occupational_safety_and_health"}],"links":[{"ns":0,"exists":"","*":"Biological safety cabinet"},{"ns":0,"exists":"","*":"Centers for Disease Control and Prevention"},{"ns":0,"exists":"","*":"Chemotherapy"},{"ns":0,"exists":"","*":"Cochrane review"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"FDA"},{"ns":0,"exists":"","*":"Hazardous drugs"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"MD Anderson"},{"ns":0,"exists":"","*":"National Institute for Occupational Safety and Health"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"*":"International Society of Oncology Pharmacy Practitioners"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Citation"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["//www.ncbi.nlm.nih.gov/pmc/articles/PMC3698436","//doi.org/10.1186/2193-1801-2-273","//www.worldcat.org/issn/2193-1801","//www.ncbi.nlm.nih.gov/pubmed/23853750","//doi.org/10.1002/14651858.CD012860.pub2","https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy/how-chemotherapy-drugs-work.html","https://www.researchandmarkets.com/research/z6wrsj/closed_system?w=5","http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD012860.pub2/full","//doi.org/10.1002/14651858.cd012860.pub2/full","https://www.pppmag.com/article/1638/","https://www.cdc.gov/niosh/docs/2004-165/2004-165d.html","http://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-0003","http://www.pharmacytimes.com/publications/health-system-edition/2016/may2016/closed-system-transfer-devices-design-characteristics-and-evolving-performance-standards","https://www.cdc.gov/od/ohs/biosfty/bsc/bsc.htm","https://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-0007","https://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-0027","https://www.regulations.gov/#!documentDetail;D=CDC-2015-0075-002"],"sections":[{"toclevel":1,"level":"2","line":"Medical use","number":"1","index":"1","fromtitle":"Closed_system_drug_transfer_device","byteoffset":1136,"anchor":"Medical_use"},{"toclevel":1,"level":"2","line":"Efficacy","number":"2","index":"2","fromtitle":"Closed_system_drug_transfer_device","byteoffset":2837,"anchor":"Efficacy"},{"toclevel":1,"level":"2","line":"History","number":"3","index":"3","fromtitle":"Closed_system_drug_transfer_device","byteoffset":4642,"anchor":"History"},{"toclevel":1,"level":"2","line":"Definition","number":"4","index":"4","fromtitle":"Closed_system_drug_transfer_device","byteoffset":5386,"anchor":"Definition"},{"toclevel":2,"level":"3","line":"NIOSH","number":"4.1","index":"5","fromtitle":"Closed_system_drug_transfer_device","byteoffset":6042,"anchor":"NIOSH"},{"toclevel":2,"level":"3","line":"ISOPP","number":"4.2","index":"6","fromtitle":"Closed_system_drug_transfer_device","byteoffset":7918,"anchor":"ISOPP"},{"toclevel":2,"level":"3","line":"NIOSH Vapor Containment Protocol Proposal Comment Period Developments","number":"4.3","index":"7","fromtitle":"Closed_system_drug_transfer_device","byteoffset":8815,"anchor":"NIOSH_Vapor_Containment_Protocol_Proposal_Comment_Period_Developments"},{"toclevel":2,"level":"3","line":"Solutions","number":"4.4","index":"8","fromtitle":"Closed_system_drug_transfer_device","byteoffset":10192,"anchor":"Solutions"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"9","fromtitle":"Closed_system_drug_transfer_device","byteoffset":10858,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Closed system drug transfer device","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q5135358"}]}}